14.04.2020 | Antikörper in der Onkologie | International Research Highlight | Onlineartikel
International Research Highlight
Immunotherapy: B cells and TLSs facilitate a response to ICI
Tumour-infiltrating B cells have been detected in different solid tumour types, but their role in cancer remains unclear. Now, the findings of three independent studies published simultaneously in Nature indicate that B cells and tertiary lymphoid structures (TLSs) are key determinants of a response to immune-checkpoint inhibition (ICI).